Valuation: Toho Holdings Co., Ltd.

Market Cap 248B 1.57B 1.36B 1.27B 1.17B 2.19B 150B 2.23B 14.92B 5.85B 75.08B 5.91B 5.78B P/E 2027 *
20.8x
P/E 2028 * 18.5x
Enterprise Value 248B 1.57B 1.36B 1.27B 1.17B 2.19B 150B 2.23B 14.92B 5.85B 75.08B 5.91B 5.78B EV / Sales 2027 *
0.15x
EV / Sales 2028 * 0.15x
Free-Float
76.64%
Yield 2027 *
4.74%
Yield 2028 * 4.28%
02:54am Toho Holdings to Absorb Information Processing Subsidiary MT
08-05 Toho Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
06-30 Toho Holdings Co., Ltd. agreed to acquire an unknown majority stake in Ishin Pharma Co., Ltd. CI
06-30 GNI Group Ltd. completed the acquisition of AYUMI Pharmaceutical Corporation from Blackstone Inc. (NYSE:BX), Toho Holdings Co., Ltd. and Hisamitsu Pharmaceutical Co., Inc. CI
06-17 3D Investment Partners Pte. Ltd. Urges Shareholders of Toho Holdings Co., Ltd. CI
06-09 Toho Holdings Co., Ltd. Urging Shareholders to Vote Against Poison Pill Proposal CI
06-07 GNI to Acquire Ayumi Pharmaceutical in 44.8 Billion Yen Deal; Blackstone-Backed Fund Becomes Top Shareholder MT
06-04 GNI Group Ltd. agreed to acquire AYUMI Pharmaceutical Corporation from Blackstone Inc. (NYSE:BX), Toho Holdings Co., Ltd. and Hisamitsu Pharmaceutical Co., Inc. for ¥44.8 billion. CI
06-01 3D Investment Partners Urges Shareholders to Vote Against Toho HD?s Proposal 4 Poison Pill CI
05-13 Toho Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2026 CI
05-10 MP-2605 K.K. completed the acquisition of 53.42% stake in Solasto Corporation from Daito Trust Construction Co.,Ltd., Toho Holdings Co., Ltd., Goldman Sachs International, JPMorgan Securities Japan Co., Ltd., Medical Concierge Co., Ltd., The Master Trust Bank of Japan, Ltd., Custody Bank of Japan, Ltd. and others for ¥54.12 billion. CI
05-07 Japan's Listed Companies Face Investor Pressure on 20 Trillion Yen Real Estate Gains MT
04-30 Japan Shares Drop on Soft Output Data, Middle East Risks MT
1 day+1.17%
1 week-9.10%
Current month-5.38%
1 month-4.07%
3 months-12.75%
6 months-18.43%
Current year-18.64%
1 week 3,574
Extreme 3574
3,990
1 month 3,574
Extreme 3574
4,403
Current year 3,574
Extreme 3574
5,031
1 year 3,574
Extreme 3574
5,726
3 years 2,776
Extreme 2776
5,726
5 years 1,678
Extreme 1678
5,726
10 years 1,653
Extreme 1653
5,726
Manager TitleAgeSince
Chief Executive Officer 74 2024-06-26
Director of Finance/CFO - -
Chief Operating Officer 61 2022-05-31
Director TitleAgeSince
Director/Board Member 60 2001-05-31
Director/Board Member 74 2015-05-31
Director/Board Member 61 2016-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.17%-9.10%-28.16%+39.02% 1.55B
+1.40%+3.14%+33.14%+109.14% 102B
+0.31%+3.67%+55.45%+158.59% 55.66B
-0.33%+0.68%+3.11%+282.05% 24.19B
+1.64%-0.36%-12.66%-16.42% 8.17B
+4.21%-1.70%-34.11%-29.76% 7.23B
-0.82%-3.91%-9.98%-31.06% 6.8B
+0.14%+0.19%+19.41%+18.80% 6.16B
-1.85%-4.36%-3.92%+19.39% 5.14B
+0.81%-3.11%-6.38%-6.90% 3.66B
Average +0.74%-1.47%+1.59%+54.29% 22.01B
Weighted average by Cap. +0.86%+1.28%+27.90%+120.05%

Financials

2027 *2028 *
Net sales 1,623B 10.29B 8.9B 8.31B 7.63B 14.34B 979B 14.57B 97.53B 38.28B 491B 38.64B 37.8B 1,655B 10.49B 9.08B 8.48B 7.78B 14.63B 999B 14.86B 99.45B 39.04B 501B 39.41B 38.54B
Net income 11.54B 73.21M 63.32M 59.14M 54.25M 102M 6.97B 104M 694M 272M 3.49B 275M 269M 13.48B 85.47M 73.93M 69.04M 63.33M 119M 8.13B 121M 810M 318M 4.08B 321M 314M
Net Debt - -
Logo Toho Holdings Co., Ltd.
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.
Employees
7,675
Date Price Change Volume
26-08-07 JP¥3,798.00 +1.17% 191,800
26-08-06 JP¥3,754.00 +3.90% 202,700
26-08-05 JP¥3,613.00 -7.60% 334,300
26-08-04 JP¥3,910.00 -1.86% 157,400
26-08-03 JP¥3,984.00 -0.75% 158,100
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
3,798.00JPY
Average target price
4,050.00JPY
Spread / Average Target
+6.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 8129 Stock